Document is current
Any future updates will be listed below
-
Authors
Leibowitz, Jonathan S.
Kumi, Frank
Naseif, Araksy
Leibowitz, Edward J.
Baumeister, Conrad https://orcid.org/0009-0006-7099-3767
-
Funding
Funding for this research was provided by:
Comenius University in Bratislava
- License Information
-
More Information
Article History
Received: 16 June 2025
Revised: 31 July 2025
Accepted: 26 August 2025
First Online: 6 September 2025
Declarations
:
: The authors declare no competing interests.
: This work involved retrospective observational review of routine clinical data and did not require formal institutional review board (IRB) approval. All procedures were conducted in accordance with ethical guidelines and regulations.
: All individuals received off-label sirolimus treatment as part of standard clinical care. They were informed of the off-label nature of the therapy and provided written consent for the use of their anonymized clinical data in this analysis.
: Written consent for publication was obtained from all participants. Each individual gave explicit permission for the use of their anonymized data in this work and its dissemination in scientific publications.
